S100 BASED TREATMENT OF CARDIAC POWER FAILURE
- 专利权人:
- 发明人:
- 申请号：
- EP14777630.6
- 公开号：
- EP3052118A1
- 申请日:
- 2014.10.01
- 申请国别(地区):
- EP
- 年份:
- 2016
- 代理人:
- 摘要：
- The present invention relates to S100 protein and nuclei acids encoding S100 protein for enhancing the cardiac power as well as vectors and pharmaceuticals comprising the same and uses thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Treatment of cardiac power failure based on S100
- Pharmaceutical compositions containing peptides derived from human BPLP protein
- Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and anti-angiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseases
- PHARMACEUTICAL COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, FUSION PROTEIN IN WHICH TUMOR-PENETRATING PEPTIDE AND ANTI-ANGIOGENESIS AGENT ARE FUSED, FOR PREVENTING AND TREATING CANCER OR ANGIOGENESIS-RELATED DISEASES
- CONJUGATE OF VEGF-GRAB PROTEIN AND DRUG, AND USE THEREOF
